Psoriasis

Psoriasis is a relatively common skin condition, with a global prevalence estimated at around 2-3% of the population. Psoriasis is an overproduction of skin cells leading to thickened red plaques and inflammation. It is an immune modulation but the exact mechanisms are unclear. Psoriasis can also affect the joints causing destructive arthritis with significant pain and disability. It is sometimes associated with cardiovascular disease, depression, and obesity. MetroBoston conducts clinical trials with the goal of improving plaque psoriasis and improving the quality of life in those with plaque psoriasis.